<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang X</submitter><funding>Natural Science Foundation of Hebei Province</funding><funding>National Natural Science Foundation of China</funding><funding>Natural Science Foundation of Hebei Province (Hebei Provincial Natural Science Foundation)</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>642</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8222353</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(7)</volume><pubmed_abstract>Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus (DM) and the dysfunction of Schwann cells plays an important role in the pathogenesis of DPN. Thioredoxin-interacting protein (TXNIP) is known as an inhibitor of thioredoxin and associated with oxidative stress and inflammation. However, whether TXNIP is involved in dysfunction of Schwann cells of DPN and the exact mechanism is still not known. In this study, we first reported that TXNIP expression was significantly increased in the sciatic nerves of diabetic mice, accompanied by abnormal electrophysiological indexes and myelin sheath structure. Similarly, in vitro cultured Schwann cells TXNIP was evidently enhanced by high glucose stimulation. Again, the function experiment found that knockdown of TX</pubmed_abstract><journal>Cell death &amp; disease</journal><pubmed_title>TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression.</pubmed_title><pmcid>PMC8222353</pmcid><funding_grant_id>81971182</funding_grant_id><funding_grant_id>81700715</funding_grant_id><funding_grant_id>H2018206096</funding_grant_id><funding_grant_id>H2019206463</funding_grant_id><pubmed_authors>Zhao S</pubmed_authors><pubmed_authors>Hao J</pubmed_authors><pubmed_authors>Zhu L</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Yuan Q</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Kong D</pubmed_authors><pubmed_authors>Wang H</pubmed_authors></additional><is_claimable>false</is_claimable><name>TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression.</name><description>Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus (DM) and the dysfunction of Schwann cells plays an important role in the pathogenesis of DPN. Thioredoxin-interacting protein (TXNIP) is known as an inhibitor of thioredoxin and associated with oxidative stress and inflammation. However, whether TXNIP is involved in dysfunction of Schwann cells of DPN and the exact mechanism is still not known. In this study, we first reported that TXNIP expression was significantly increased in the sciatic nerves of diabetic mice, accompanied by abnormal electrophysiological indexes and myelin sheath structure. Similarly, in vitro cultured Schwann cells TXNIP was evidently enhanced by high glucose stimulation. Again, the function experiment found that knockdown of TX</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2026-05-07T22:26:35.522Z</modification><creation>2022-02-10T18:52:15.737Z</creation></dates><accession>S-EPMC8222353</accession><cross_references><pubmed>34162834</pubmed><doi>10.1038/s41419-021-03930-2</doi></cross_references></HashMap>